IFNα Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment.
Cancer Discov. 2022 Jul 6;12(7):1718-1741. doi: 10.1158/2159-8290.CD-21-1022.
Cancer Discov. 2022.
PMID: 35412588